N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients

被引:90
作者
Meyer, Brigitte
Huelsmann, Martin
Wexberg, Paul
Delle Karth, Georg
Berger, Rudolf
Moertl, Deddo
Szekeres, Thomas
Pacher, Richard
Heinz, Gottfried [1 ]
机构
[1] Med Univ Vienna, Dept Cardiol, Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria
[3] Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Gen Hosp Vienna, Vienna, Austria
关键词
natriuretic peptides; B-type natriuretic peptide; prognosis; critically ill;
D O I
10.1097/01.CCM.0000284509.23439.5B
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives. Natriuretic peptides emerged during recent years as potent prognostic markers in patents with heart failure and acute myocardial infarction. In addition, natriuretic peptides show strong predictive value in patients with pulmonary embolism, sepsis, renal failure, and shock. The present study tests the prognostic information of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) in an unselected cohort of critically ill patients. Design: Prospective, observational study. Setting: A tertiary intensive care unit in a university hospital. Patients: A total of 289 consecutive patients admitted to the intensive care unit during a 16-month period with the following data: age 64 +/- 14 yrs, male n = 191, Simplified Acute Physiology Score 11 of 52 +/- 24, mechanical ventilation n = 180 (620/6), vasopressors n = 179 (620/6), renal failure n = 24 (80/6). Interventions: None. Measurements and Main Results: Plasma NT-pro-BNP samples (Roche Diagnostics) were obtained on intensive care unit admission. Data are given as median [range]. Intensive care unit survivors had significantly lower NT-pro-BNP values compared with intensive care unit nonsurvivors (3394 [24-35,000] vs. 6776 [303-35,000] pg/mL, survivors vs. nonsurvivors, respectively, p = .001). Hospital survivors were characterized by significantly lower NT-pro-BNP values (2656 [24-35,000] vs. 8390 303-35,000] pg/mL, survivors vs. nonsurvivors, respectively, p = .001). NT-pro-BNP levels were not significantly different in patients with primary cardiac diagnosis compared with those with a noncardiac admission diagnosis (4794 [26-35,000], n = 202 vs. 3349 [24-35,000], n = 87, cardiac vs. noncardiac, respectively, p = .28). In a logistic regression model, Simplified Acute Physiology Score 11 and NT-pro-BNP were independently associated with hospital survival (X-2 = 35.6, p = .0001 and X2 = 11.3, p = .0008, Simplified Acute Physiology Score 11 and NT-pro-BNP, respectively). Areas under the receiver operating characteristic curves of NT-pro-BNP and Simplified Acute Physiology Score 11 were not statistically significant different regarding the prediction of outcome. Conclusions: NT-pro-BNP on admission is an independent prognostic marker of outcome in an unselected cohort of critically ill patients. A single measurement of NT-pro-BNP might facilitate triage of emergency and intensive care unit patients.
引用
收藏
页码:2268 / 2273
页数:6
相关论文
共 49 条
[1]   Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement - Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study [J].
Anwaruddin, S ;
Lloyd-Jones, DM ;
Baggish, A ;
Chen, A ;
Krauser, D ;
Tung, R ;
Chae, C ;
Januzzi, JL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) :91-97
[2]   B-type natriuretic peptide - A window to the heart [J].
Baughman, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (03) :158-159
[3]   B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].
Berger, R ;
Huelsman, M ;
Strecker, K ;
Bojic, A ;
Moser, P ;
Stanek, B ;
Pacher, R .
CIRCULATION, 2002, 105 (20) :2392-2397
[4]   Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis [J].
Bergler-Klein, J ;
Klaar, U ;
Heger, M ;
Rosenhek, R ;
Mundigler, G ;
Gabriel, H ;
Binder, T ;
Pacher, R ;
Maurer, G ;
Baumgartner, H .
CIRCULATION, 2004, 109 (19) :2302-2308
[5]   Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis [J].
Brueckmann, M ;
Huhle, G ;
Lang, S ;
Haase, KK ;
Bertsch, T ;
Weiss, C ;
Kaden, JJ ;
Putensen, C ;
Borggrefe, M ;
Hoffmann, U .
CIRCULATION, 2005, 112 (04) :527-534
[6]   Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis [J].
Charpentier, J ;
Luyt, CE ;
Fulla, Y ;
Vinsonneau, C ;
Cariou, A ;
Grabar, S ;
Dhainaut, JF ;
Mira, JP ;
Chiche, JD .
CRITICAL CARE MEDICINE, 2004, 32 (03) :660-665
[7]   Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting [J].
Dao, Q ;
Krishnaswamy, P ;
Kazanegra, R ;
Harrison, A ;
Amirnovin, R ;
Lenert, L ;
Clopton, P ;
Alberto, J ;
Hlavin, P ;
Maisel, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :379-385
[8]   The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].
de Lemos, JA ;
Morrow, DA ;
Bentley, JH ;
Omland, T ;
Sabatine, MS ;
McCabe, CH ;
Hall, C ;
Cannon, CP ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021
[9]   B-type natriuretic peptide in organic mitral regurgitation - Determinants and impact on outcome [J].
Detaint, D ;
Messika-Zeitoun, D ;
Avierinos, JF ;
Scott, C ;
Chen, H ;
Burnett, JC ;
Enriquez-Sarano, M .
CIRCULATION, 2005, 111 (18) :2391-2397
[10]   Cardiac troponin: a new serum marker of myocardial injury in sepsis [J].
Fernandes, CJ ;
Akamine, N ;
Knobel, E .
INTENSIVE CARE MEDICINE, 1999, 25 (10) :1165-1168